04135nam a22005655i 4500 978-981-97-2954-8 DE-He213 20251030112244.0 cr nn 008mamaa 240530s2024 si | s |||| 0|eng d 9789819729548 978-981-97-2954-8 10.1007/978-981-97-2954-8 doi K4240-4343 LNJ bicssc LAW000000 bisacsh LNJ thema Sharma, Kavita. author. (orcid)0000-0001-7262-4494 https://orcid.org/0000-0001-7262-4494 aut http://id.loc.gov/vocabulary/relators/aut 77885 Artificial Intelligence in Drug Development [electronic resource] : Patenting and Regulatory Aspects / by Kavita Sharma, Padmavati Manchikanti. 1st ed. 2024. Singapore : Springer Nature Singapore : Imprint: Springer, 2024. XIII, 149 p. 35 illus., 33 illus. in color. online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Frontiers of Artificial Intelligence, Ethics and Multidisciplinary Applications, 2731-8133 Artificial Intelligence in Drug Development - Nature and Scope -- Analysis of AI Related Patents in the Healthcare -- Regulation of AI in Drug Development -- Policy and Regulation for AI for Indian Drug and Healthcare Industry -- Way forward for Patenting and Regulation in relation to AI. This book discusses how Artificial Intelligence developments have revolutionized the area of medicine and how companies use them to develop applications. While the book covers the growth of AI in medicine and the early developments in AI based medical tools, it provides an in-depth analysis of the current developments in relation to the area of medical diagnostics. The book focuses on how enterprises and institutes have developed their intellectual property portfolio, particularly patents, in this area. Cross-country patenting analysis helps in understanding key areas of growth in certain markets and also company strategies and arrangements. The introduction of AI based products in market is subject to regulation. The developments in policy and regulation influence the development and deployment of such products into the market. This book brings focus to the development of policy and regulation and how regulatory developments impact the introduction of AI-based healthcare products from a cross-country perspective. Further, how regulatory developments lead to the evolution of standards, build reliability and safety in this area are also examined. The unique aspect of this book is the comprehensive coverage of the dual aspects of the nature and scope of AI-based innovations in health care and the related drug regulatory aspects which are imperative for the understanding for students, researchers, and those who work in this area. Information technology Law and legislation. 67243 Mass media Law and legislation. 67244 Health services administration. 61649 Artificial intelligence. 58441 IT Law, Media Law, Intellectual Property. 67246 Health Care Management. 67006 Artificial Intelligence. 58441 Manchikanti, Padmavati. author. aut http://id.loc.gov/vocabulary/relators/aut 77886 SpringerLink (Online service) Springer Nature eBook Printed edition: 9789819729531 Printed edition: 9789819729555 Printed edition: 9789819729562 Frontiers of Artificial Intelligence, Ethics and Multidisciplinary Applications, 2731-8133 71701 https://doi.org/10.1007/978-981-97-2954-8 ZDB-2-LCR ZDB-2-SXLC 60313 60313